SEARCH RESULTS FOR IPA
QIAGEN IPA
Identifying novel drug targets in paraganglioma
In disease research, understanding the key genes involved and how they interact to...
QIAGEN IPA
Transcriptional response to animal feed supplemented with plant-based...
In recent years there has been a rapid trend to end use of antibiotic growth promoters...
QIAGEN IPA
Drug repurposing: from large-scale biological data to therapeutics
One of the challenges we are facing today is the high cost and slow pace of drug...
Tutorials
Easily process your FASTQ files
Do you ever get stuck processing raw FASTQ data or cell matrix data from your RNA-seq,...
QIAGEN OmicSoft and Biomedical Knowledge Base
Checkpoint inhibitors in the context of biomarkers, drug targets and pathways
In this training, we will focus on how you can use QIAGEN Omicsoft Studio and QIAGEN...
QIAGEN OmicSoft and Biomedical Knowledge Base
Drug treatment data investigation using Omicsoft and Ingenuity Pathway Analysis
In this training, the trainer will go over how to utilize public drug treatment data...
QIAGEN OmicSoft and Biomedical Knowledge Base
Checkpoint inhibitors investigation in context of biomarkers, drug targets...
This training will focus on how QIAGEN Omicsoft Studio and IPA can be used to discover...
QIAGEN OmicSoft and Biomedical Knowledge Base
Drug MOA and disease pathology investigation using QIAGEN Biomedical KB-HD
Many research groups worldwide are investing significant time and resources in studying...
QIAGEN OmicSoft and Biomedical Knowledge Base
QIAGEN Biomedical KB-HD: data- and analytics-driven drug discovery
Ingenuity Pathway Analysis (IPA), currently cited in tens of thousands of publications...
QIAGEN OmicSoft and Biomedical Knowledge Base
Public single-cell RNA-seq data investigation using QIAGEN OmicSoft and...
Single-cell RNA-sequencing (scRNA-seq) is widely used to investigate tissue...
QIAGEN CLC Genomics
RNA-seq data analysis and interpretation with Sankey plot update
During this 120-minute training, we’ll teach you how to easily analyze and interpret...